Secondary Logo

Journal Logo

September 23, 2005 - Volume 19 - Issue 14
pp: 1443-1553

Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adults

Lalezari, Jacob; Thompson, Melanie; Kumar, Priny; More

AIDS. 19(14):1443-1448, September 23, 2005.

High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level

Yu, Xu G; Lichterfeld, Mathias; Perkins, Beth; More

AIDS. 19(14):1449-1456, September 23, 2005.


Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin

Manosuthi, Weerawat; Sungkanuparph, Somnuek; Thakkinstian, Ammarin; More

AIDS. 19(14):1481-1486, September 23, 2005.


Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine

Chokephaibulkit, Kulkanya; Plipat, Nottasorn; Cressey, Tim R; More

AIDS. 19(14):1495-1499, September 23, 2005.

Outcomes of a randomized, controlled community-level HIV prevention intervention for adolescents in low-income housing developments

Sikkema, Kathleen J; Anderson, Eileen S; Kelly, Jeffrey A; More

AIDS. 19(14):1509-1516, September 23, 2005.